Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul;46(7):1417-1427.
doi: 10.1007/s00259-019-04309-4. Epub 2019 Apr 2.

Prognostic Value of Metabolic Tumour Volume on Baseline 18 F-FDG PET/CT in Addition to NCCN-IPI in Patients With Diffuse Large B-cell Lymphoma: Further Stratification of the Group With a High-Risk NCCN-IPI

Affiliations

Prognostic Value of Metabolic Tumour Volume on Baseline 18 F-FDG PET/CT in Addition to NCCN-IPI in Patients With Diffuse Large B-cell Lymphoma: Further Stratification of the Group With a High-Risk NCCN-IPI

Qaid Ahmed Shagera et al. Eur J Nucl Med Mol Imaging. .

Abstract

Purpose: The purpose of this study was to determine the prognostic value of metabolic volumetric parameters as a quantitative index on pre-treatment 18F-FDG PET/CT in addition to the National Comprehensive Cancer Network International Prognostic Index (NCCN-IPI) in patients with diffuse large B-cell lymphoma (DLBCL).

Methods: A total of 103 consecutive patients with DLBCL and baseline FDG PET/CT were retrospectively evaluated. Quantitative metabolic parameters, including total metabolic tumour volume (TMTV) using a standardized uptake value (SUV) of ≥2.5 as the threshold, were estimated. Receiver operating characteristic curve analysis was used to determine the optimal cut-off values for the metabolic parameters. The relationships between study variables and patient survival were tested using Cox regression analysis. Patient survival rates were derived from Kaplan-Meier curves and compared using the log-rank test.

Results: Median follow-up was 34 months. In patients with a low TMTV (<249 cm3), the 3-year progression free survival (PFS) rate was 83% and the overall survival (OS) rate was 92%, in contrast to 41% and 57%, respectively, in those with a high TMTV (≥249 cm3). In univariate analysis, a high TMTV and NCCN-IPI ≥4 were associated with inferior PFS and OS (P < 0.0001 for all), as was a high total lesion glycolysis (P = 0.004 and P = 0.005, respectively). In multivariate analysis, TMTV and NCCN-IPI were independent predictors of PFS (hazard ratio, HR, 3.11, 95% confidence interval, CI, 1.37-7.07, P = 0.007, and HR 3.42, 95% CI 1.36-8.59, P = 0.009, respectively) and OS (HR 3.41, 95% CI 1.24-9.38, P = 0.017, and HR 5.06, 95% CI 1.46-17.60, P = 0.014, respectively). TMTV was able to separate patients with a high-risk NCCN-IPI of ≥4 (n = 62) into two groups with significantly different outcomes; patients with low TMTV (n = 16) had a 3-year PFS rate of 75% and an OS rate of 88%, while those with a high TMTV had a 3-year PFS rate of 32% and an OS rate of 47% (χ2 = 7.92, P = 0.005, and χ2 = 8.26, P = 0.004, respectively). However, regardless of TMTV, patients with a low-risk NCCN-IPI of <4 (n = 41) had excellent outcomes (3-year PFS and OS rates of 85% and 95%, respectively).

Conclusion: Pretreatment TMTV was an independent predictor of survival in patients with DLBCL. Importantly, TMTV had an additive prognostic value in patients with a high-risk NCCN-IPI. Thus, the combination of baseline TMTV with NCCN-IPI may improve the prognostication and may be helpful guide the decision for intensive therapy and clinical trials, especially in DLBCL patients with a high-risk NCCN-IPI.

Keywords: Diffuse large B-cell lymphoma; FDG PET/CT; Metabolic tumour volume; Prognosis.

Similar articles

See all similar articles

Cited by 3 articles

References

    1. N Engl J Med. 2002 Jan 24;346(4):235-42 - PubMed
    1. Blood. 2004 Jan 1;103(1):275-82 - PubMed
    1. Eur J Nucl Med Mol Imaging. 2004 Mar;31(3):325-9 - PubMed
    1. Hematology Am Soc Hematol Educ Program. 2004;:221-36 - PubMed
    1. J Clin Oncol. 2005 Jul 20;23(21):4643-51 - PubMed

LinkOut - more resources

Feedback